AnaptysBio
ANAB
ANAB
122 hedge funds and large institutions have $628M invested in AnaptysBio in 2021 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 41 increasing their positions, 39 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
10% less funds holding
Funds holding: 136 → 122 (-14)
50% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 26
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
122
Holding in Top 10
2
Calls
$7.66M
Puts
$7.93M
Top Buyers
| 1 | +$84.7M | |
| 2 | +$25.6M | |
| 3 | +$11.8M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$9.24M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$4.87M |
Top Sellers
| 1 | -$26.1M | |
| 2 | -$25.7M | |
| 3 | -$16.6M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$16.3M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.97M |